Ed Gates has practiced for 35 years in the pharmaceutical, biotechnology and medical arts. Clients describe Ed as “strategic”, “effective” and “persuasive”. He is perennially recognized by Chambers, Best Lawyers in America, and Massachusetts Super Lawyers, among many others.
Ed recently stepped down after serving as the firm’s Chairman for 15 years. The firm has benefited from Ed’s service in other capacities, as its President and Managing Partner, a member of its strategic planning committee over a 20 year span, and as the founder of its biotechnology and pharmaceutical groups.
Ed represents clients through all strata, from start-ups to fortune 500 companies as well as some of the most prestigious universities and research institutions in the world. He has helped clients from inception through successful public offerings and exits and has co-founded several biotechnology companies.
Ed’s practice spans licensing, patent portfolio development, counseling, post-grant practice, and litigation. Ed's experience helps him recognize and capture value at the intersection of technology, IP and business. His extensive experience places him in the elite of IP transaction lawyers. Known nationally for his understanding of university policy with respect to IP, Ed is effective on either side of the table in structuring technology deals arising out of universities and research institutions. He serves clients from both the firm's Boston and New York offices.
"Ed is not only a superb intellectual property attorney but also has proven indispensable in negotiating and drafting complex agreements."
"Ed has been our equalizer."
"Ed grasps the workings of complex technologies, unravels knotty contract language, and communicates straightforward solutions in a positive manner, enhancing relationships in intricate, deadline-driven deals."
"Ed’s counsel has been invaluable in turning technologies with scientific promise into a portfolio of intellectual property at the center of deals recognized at industry gatherings and in business media coverage."